following statement was released by the rating agency) CHICAGO, August 20 (Fitch) Fitch Ratings has affirmed St . Jude Medical , Inc.'s ( STJ ) Issuer Default Rating (IDR) at 'A' with a Stable Rating Outlook. Fitch has also affirmed the company
discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Tuesday August 19. Bullish Calls: St Jude Medical (NYSE: STJ ): "It has the best new products. It is a buy." EOG Resources (NYSE: EOG ): "Start a position in EOG
competitors, such as Medtronic and St . Jude Medical , who can easily bid up prices ..... Technologies. Additionally, St . Jude Medical is on the warpath with its own ..... transcatheter valve. Though we think St . Jude trails Medtronic by two to three
this arena. While we had cautiously anticipated rising competition now that Medtronic has entered the U.S. and St . Jude Medical and Boston Scientific have launched in Europe, Edwards showed its own strength in both markets with its rollout
St . Jude Medical (NYSE: STJ ) declares $0.27/share quarterly dividend , in line with previous. Forward yield 1.64% Payable Oct. 31; for shareholders of record Sept. 30; ex-div Sept. 26. Post your comment!
ICD, Boston racked up 4% year-over-year ICD growth--the strongest seen in 12 quarters. Although peers St . Jude Medical and Medtronic have both launched leadless pacemakers, Boston still offers the only leadless ICD. While Boston
St . Jude Medical 's (NYSE: STJ ) Flexibility Ablation Catheter achieves CE Mark clearance in Europe. The product has a flexible tip that reduces complications
July 16 (Reuters) - Heart device maker St . Jude Medical Inc said it has no plans to jump on the consolidation bandwagon that has swept the healthcare sector in recent months and is not
St . Jude Medical Inc. (NYSE: STJ ) Q2 2014 Results Earnings Conference ..... Presentation Operator Welcome to the St . Jude Medical Second Quarter 2014 Earnings Conference ..... and Chief Executive Officer of St . Jude Medical . Before we begin, let me remind
July 16 (Reuters) - Heart device maker St . Jude Medical Inc reported a quarterly net profit that more than doubled as expenses fell.